Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Calmette-Guerin (BCG) vaccination]

F Bonnaud1

  • 1Comité national contre les maladies respiratoires et la tuberculose (CNMRT), Paris.

La Revue Du Praticien
|June 1, 1996
PubMed
Summary

The Bacillus Calmette-Guérin (BCG) vaccine remains crucial for tuberculosis prevention, especially in endemic regions. Recent research confirms its efficacy and safety, with future applications enhanced by molecular biology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The Lady Windermere syndrome: clinical and bacteriological data and progress in seven cases].

Revue des maladies respiratoires·2012
Same author

Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging.

Anticancer research·2010
Same author

[Age and management decisions in patients with primary lung cancer].

Revue des maladies respiratoires·2008
Same author

Clinico-biological characteristics of flow cytometry applied to hypersensitivity to NSAIDs.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2007
Same author

Use of both CD63 up regulation and IgE down regulation for the flow cytometric analysis of allergen induced basophil activation. Definition of an activation index.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2007
Same author

Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis resurgence globally necessitates renewed focus on prevention strategies.
  • The Bacillus Calmette-Guérin (BCG) vaccine, used since 1921, has faced ongoing debate regarding its effectiveness.
  • Recent studies increasingly validate the BCG vaccine's utility, particularly in high-incidence tuberculosis areas.

Purpose:

  • To re-evaluate the role and efficacy of the BCG vaccine in contemporary tuberculosis prevention.
  • To analyze the impact of BCG vaccination on individual and public health protection against tuberculosis.
  • To assess the safety profile and future potential of the BCG vaccine.

Summary:

  • The BCG vaccine's intradermal administration technique has remained consistent.
  • While its impact on individual protection is debated, its role in broader tuberculosis prevention warrants careful consideration.
  • The vaccine demonstrates minor side effects when administered according to established guidelines.

Impact:

  • The BCG vaccine continues to be a vital tool in the global fight against tuberculosis.
  • Advances in molecular biology and mycobacterial genetics suggest promising future developments for BCG vaccine applications.
  • Understanding BCG's effectiveness is critical for public health policies addressing the global tuberculosis burden.

Related Experiment Videos